Tag: Mylan
US: Sanofi seeks billions in EpiPen antitrust suit
Sanofi wants Mylan to pay up to US$11.7 billion in damages for engaging in a scheme to squelch competition to its EpiPen allergy treatment,...
US: Celgene to pay Mylan $62M to resolve cancer drug antitrust...
Mylan announced Celgene will pay it US$62 million to resolve a lawsuit alleging the drugmaker improperly stifled competition for its cancer treatment drugs Thalomid...
US: Pfizer and Mylan reportedly near merger deal for low-priced drugs
Pfizer plans to combine its off-patent business, which includes Lipitor cholesterol pills and male-impotence drug Viagra, with Mylan NV and form a generic drug...
US: Mylan seeks dismissal of Sanofi’s EpiPen antitrust suit
Mylan is urging a federal judge to reject rival drugmaker Sanofi’s claims the company engaged in a scheme to squelch competition to its EpiPen allergy treatment,...
US: Mylan antitrust lawsuit filed by 44 AGs transferred to PA...
A federal lawsuit filed by West Virginia and 43 other states against Mylan Pharmaceuticals has been transferred from the federal court in Connecticut to...
US: EpiPen makers must face antitrust claims, judge rules
A Kansas district court judge has dismissed motions by Mylan, Pfizer, and others to dismiss class action complaints accusing them of RICO Act violations,...
US: Humana sues generics manufacturers over price-fixing
Humana has brought a lawsuit against 37 pharmaceutical companies including Novartis, Mylan, and Teva, alleging price fixing of numerous generic drugs.
The conspiracy allegedly increased...
Italy: Mylan faces new probe
Pharmaceutical company Mylan NV announced that certain employees of Mylan in Italy were served with search warrants issued by the public prosecutor’s office in...
US: DAs get personal on pharma, name Mylan, Emcure execs
Mylan president Rajiv Malik has been named in an expanded federal lawsuit filed by attorneys general in nearly every state, that accuses Mylan and...
US: Mylan reaches EpiPen Settlment for $465m
On August 17, Mylan and federal investigators finalized a US$465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication...
